According to this study, the global CAS9 Technology market size will reach US$ million by 2028.

This report presents a comprehensive overview, market shares, and growth opportunities of CAS9 Technology market by product type, application, key players and key regions and countries.

Segmentation by product type:

Genome Engineering

Disease Models

Segmentation by Application:

Biotechnology & Pharmaceutical Companies

Academic & Research Institutes

This report also splits the market by region:

United States

China

Europe

Other regions:

Japan

South Korea

Southeast Asia

Rest of world

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:

Cellecta Inc.

abm Inc.

GenScript

CRISPR Therapeutic

Intellia Therapeutics Inc.

GE Healthcare

Takara Bio Inc.

AstraZeneca

PLC

Merck KGaA

Bio-Rad Laboratories Inc.

Danaher Corporation (Integrated DNA Technologies Inc.)

New England Biolabs

OriGene Technologies Inc.

Lonza Group

Thermo Fisher Scientific